EWM
RDHL

Elmwood Wealth Management’s Redhill Biopharma RDHL Stock Holding History

Elmwood Wealth Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed -$3K – 271
2021
Q4 		$3K Buy
+1
New +$4K ﹤0.01% 336
2021
Q2 		$7K Hold
1
– – ﹤0.01% 274
2021
Q1 		$7K Buy
+1
New +$8.39K ﹤0.01% 263

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Elmwood Wealth Management's RDHL Position: Q1 2022 in Review

Elmwood Wealth Management sold out of Redhill Biopharma (RDHL) in Q1 2022, closing a stake of 1 share — an estimated $3K sold.

Elmwood Wealth Management first reported a position in RDHL in Q1 2021 and held it in 3 quarters. The position peaked at $7K in Q2 2021. 43 funds tracked by Wall St. Rank hold RDHL as of Q1 2022.

  • Elmwood Wealth Management reported no remaining Redhill Biopharma position as of Q1 2022 after selling out during the quarter.
  • Elmwood Wealth Management sold 1 Redhill Biopharma share in Q1 2022, an estimated $3K.
  • Elmwood Wealth Management first reported a position in Redhill Biopharma in Q1 2021 and held it in 3 quarters.
  • Elmwood Wealth Management's Redhill Biopharma position peaked at $7K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2022.

Based on Elmwood Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.